Q1 2024 Holdings
Filed 2024-05-15 | 72 holdings | $439.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $40.9M | 431,215 | 9.3% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $35.7M | 13,680,554 | 8.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $27.9M | 398,100 | 6.4% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $19.6M | 446,341 | 4.5% |
| Merus N V | COM | N5749R100 | $17.1M | 378,995 | 3.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $16.5M | 511,894 | 3.8% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $15.9M | 194,117 | 3.6% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $15.7M | 659,574 | 3.6% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $14.1M | 102,500 | 3.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $14.0M | 92,472 | 3.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.8M | 273,739 | 2.7% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $11.0M | 666,463 | 2.5% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $10.1M | 106,763 | 2.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.9M | 71,615 | 2.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $9.6M | 806,973 | 2.2% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $9.1M | 258,208 | 2.1% |
| Dexcom Inc(DXCM) | COM | 252131107 | $9.1M | 65,552 | 2.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $8.8M | 412,663 | 2.0% |
| Atricure Inc(ATRC) | COM | 04963C209 | $8.2M | 271,029 | 1.9% |
| Morphic Holding Inc | COM | 61775R105 | $8.2M | 231,748 | 1.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $7.6M | 935,894 | 1.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $6.5M | 118,730 | 1.5% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $6.4M | 1,204,051 | 1.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $5.6M | 306,197 | 1.3% |
| Alector Inc(ALEC) | COM | 014442107 | $5.5M | 912,928 | 1.3% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $5.5M | 1,307,407 | 1.2% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $5.0M | 656,373 | 1.1% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $4.6M | $4,000,000 | 1.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $4.5M | 67,754 | 1.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.4M | 231,717 | 1.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $4.2M | 130,175 | 1.0% |
| Perspective Therapeutics Inc | COM | 46489V104 | $3.7M | 3,103,644 | 0.8% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $3.6M | 709,500 | 0.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $3.1M | 223,265 | 0.7% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $3.1M | 1,070,548 | 0.7% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $3.0M | 122,200 | 0.7% |
| Accuray Inc(ARAY) | COM | 004397105 | $3.0M | 1,222,358 | 0.7% |
| Insulet Corp(PODD) | COM | 45784P101 | $2.7M | 15,900 | 0.6% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $2.7M | 54,995 | 0.6% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $2.7M | 188,753 | 0.6% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $2.4M | 239,194 | 0.6% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $2.1M | 500,000 | 0.5% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $2.1M | 905,582 | 0.5% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $2.0M | 243,210 | 0.5% |
| Lineage Cell Therapeutics in(LCTX) | COM | 53566P109 | $2.0M | 1,366,308 | 0.5% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.0M | 145,000 | 0.4% |
| Sutro Biopharma Inc | COM | 869367102 | $1.9M | 334,079 | 0.4% |
| Inogen Inc(INGN) | COM | 45780L104 | $1.7M | 208,790 | 0.4% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $1.7M | 1,409,262 | 0.4% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $1.6M | 297,655 | 0.4% |